Abstract
Gediminas Vidugiris1, Donna Leippe1, Mary Sobol1, Sarah Duellman1, Wenhui Zhou2, Jolanta Vidugiriene1, Jessica Merlino3, Michael Reitman4, Thomas Hengstl5, Poncho Meisenheimer2, Cristopher Cowan1, James Cali1
1Promega Corporation, Madison, WI; 2Promega Biosciences, LLC, San Luis Obispo, CA; 3Tecan Schweiz, Männedorf, Switzerland; 4Tecan US, Morrisville, NC; 5Tecan Austria GmbH, Groedig, Austria.
Robustness of bioluminescence assays makes them attractive and easily adoptable for automation and HTS applications. We describe the integration of Tecan, Hewlett Packard instrumentation capabilities with two of Promega's recently developed assays targeting cell metabolism applications:
1) Bioluminescence Live Cell Viability Assay and; 2) NAD(P)/NAD(P)H Detection Assays.